IHS马基特 INFO 深 沪
等待开盘 12-19 09:30:00 美东时间
24.2999
+0.237
+0.98%
华盛通- 最 高24.375
- 今 开24.0633
- 成交量 3621股
- 最 低 24.2832
- 昨 收 24.0633
- 总市值 8565.71万
- 52周最高 24.72
- 市盈率 静 8.08
- 换手率 0.10%
- 52周最低 17.15
- 委 比 0.00%
- 总股本 352.50万
- 历史最高 24.72
- 量 比 0.64
- 振 幅 0.38%
- 历史最低 17.15
- 每 手 1
- 风险率 1.78%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Westamerica Bancorporation Announces Stock Repurchase Plan
The Board of Directors of Westamerica Bancorporation has approved a plan to repurchase up to 2,000,000 shares of its common stock, representing approximately 8.0% of the outstanding shares as of September 30, 2025. The repurchase may occur on the open market or through private transactions before December 31, 2026. Chairman, President, and CEO David Payne highlighted the Company's financial strength, conservative risk profile, and reliable earnin...
12-18 18:25
Data Storage Corporation Provides Letter to Shareholders Highlighting 2026 Corporate Strategy
Data Storage Corporation's CEO, Chuck Piluso, outlined the company's 2026 strategy in a letter to shareholders. The plan focuses on a hybrid acquisition strategy emphasizing technology consolidation and selective investments in sectors like managed IT, cybersecurity, telecom, and UCaaS. The company aims to acquire firms with stable recurring revenue, high margins, and customer bases, viewing these as attractive targets for long-term value. The st...
12-18 13:30
Avadel Pharmaceuticals Announces Completion of Enrollment in Phase 3 REVITALYZ™ Trial in Idiopathic Hypersomnia
Avadel Pharmaceuticals completed patient enrollment in the Phase 3 REVITALYZ trial evaluating LUMRYZ as a potential treatment for idiopathic hypersomnia (IH). The trial aims to assess LUMRYZ's efficacy and safety as a once-at-bedtime treatment for IH, targeting excessive daytime sleepiness and sleep inertia. LUMRYZ, an extended-release sodium oxybate, has shown benefits for narcolepsy patients and holds potential for IH if approved. Data expected...
12-18 12:00
CVB Financial Corp. and Heritage Commerce Corp Announce Agreement to Merge
CVB Financial Corp. and Heritage Commerce Corp. have announced a definitive merger agreement valued at approximately $811 million, with Heritage merging into Citizens Business Bank. The combination creates a top-performing California business bank with $22 billion in assets, enhanced geographic coverage, and strategic growth opportunities. The transaction, expected to close in Q2 2026, is projected to boost Citizens' EPS and provide strong return...
12-17 21:15
Sealed Air Announces Expiration of "Go-Shop" Period
Transaction is Expected to Close in Mid-2026 CHARLOTTE, N.C., Dec. 17, 2025 /PRNewswire/ -- Sealed Air Corporation ("Sealed Air" or the "Company") (NYSE: SEE), a leading global provider of f...
12-17 19:50
OraSure Technologies Issues Statement Regarding Altai Capital’s Intent to Nominate Director Candidates
OraSure Technologies, Inc. (OTC: OSUR) has informed that Altai Capital has notified its intent to nominate two candidates, including Rishi Bajaj, for the 2026 Board election. However, the Board has decided not to appoint Mr. Bajaj. The Board remains committed to enhancing shareholder value and has recently refreshed its composition by adding three new independent directors. OraSure is focusing on innovation, operational efficiency, and financial ...
12-17 18:23
Inspirato Announces Agreement to be Acquired by Exclusive Investments LLC
Inspirato Incorporated, a luxury vacation club and tech company, has agreed to be acquired by Exclusive Investments LLC for $4.27 per share, valuing it at ~$59 million. The 50% premium over its Dec 16 closing price follows shareholder approval and is expected to close in early 2026. Post-acquisition, Inspirato will become private, and its stock will delist from Nasdaq. Payam Zamani, current chairman and CEO, will step down, with James Henderson o...
12-17 14:15
VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement
VYNE Therapeutics and Yarrow Bioscience announce a merger, creating Yarrow Bioscience Inc., focused on advancing YB-101, a novel TSHR antibody for Graves’ disease and thyroid eye disease. The combined company secures $200 million in pre-closing funding to support operations until 2028, with Phase 1b/2b trials in GD planned for 2026 in the U.S. and Phase 1 trials in TED ongoing in China. The merger is expected to close in Q2 2026,subject to regula...
12-17 13:00
First Community Bankshares, Inc. Announces Special Dividend
First Community Bankshares, Inc. announced a special cash dividend of $1.00 per common share, totaling approximately $18.32 million. The dividend follows the company's capital management plan, which focuses on returning excess earnings to shareholders through dividends and stock repurchases. Shareholders of record on January 2, 2026, will receive the dividend by January 16, 2026. Since 2013, the company has distributed $238 million in regular and...
12-16 22:10
Perpetua Resources Selects Hatch as EPCM for Stibnite Gold Project
Hatch is a noted leader in North American mine and process plant development. BOISE, Idaho, Dec. 16, 2025 /PRNewswire/ - Perpetua Resources Corp. (Nasdaq: PPTA / TSX: PPTA) ("Perpetua Resour...
12-16 20:01
